Waters Corporation Announces CEO Transition Plan - - BioPharm International

ADVERTISEMENT

Waters Corporation Announces CEO Transition Plan



Waters Corporation announced that Douglas A. Berthiaume will retire as CEO within the next two years.

The company’s board of directors has appointed a succession planning committee that will guide the process of selecting a successor and plans to hire an executive search firm to assist in a search, which will consider both internal and external candidates.

Berthiaume, who is 64, was appointed president and CEO of Waters Corporation in 1994 when the business was separated from Millipore, and assumed the additional role of chairman in 1996.

Source: Waters Corporation

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Novartis Sells Influenza Vaccine Business to CSL for $275 Million
October 27, 2014
Author Guidelines

Click here